Carboxylesterase 2 production and characterization in human cells: new insights into enzyme oligomerization and activity
- 487 Downloads
Carboxylesterase 2 (CES2), the main carboxylesterase expressed in human intestine, is an increasingly important enzyme in anti-cancer combined therapies for the treatment of different pathologies like colon adenocarcinoma and malignant glioma. The production of human recombinant CES2, in human embryonic kidney cells (HEK-293T cells) using serum-free media, is herein described. CES2 secretion to the media was achieved by the simple addition of an in-frame C-terminal 10× histidine tag (CES2-10xHis) without the need of addition of extra N-terminal signalling sequences or the mutation or deletion of the C-terminal HTEL motif responsible for retaining the protein in the lumen of endoplasmic reticulum. This secretion allowed a fourfold increase in CES2 production. The characterization of human recombinant CES2 showed that this protein exists in other active and inactive forms than the described 60 kDa monomer.
KeywordsCarboxylesterases Human cells Protein expression Enzyme characterization
This work was funded by Fundação para a Ciência e Tecnologia, Portugal (SFRH/BD/44025/2008, PTDC/EBB-BIO/111530/2009, PEst-OE/EQB/LA0004/2011). The authors wish to thank Dr. C. Frazão, Dr. T. M. Bandeiras and Dr. P. M. Matias for the fruitful discussions, and Dr. Júlia Costa from ITQB, Oeiras for the expertise in glycosylation.
- Hermann M, Kietzmann MU, Ivancic M, Zenzmaier C, Luiten RG, Skranc W, Wubbolts M, Winkler M, Birner-Gruenberger R, Pichler H, Schwab H (2008) Alternative pig liver esterase (APLE)—cloning, identification and functional expression in Pichia pastoris of a versatile new biocatalyst. J Biotechnol 133:301–310CrossRefGoogle Scholar
- Hicks LD, Hyatt JL, Stoddard S, Tsurkan L, Edwards CC, Wadkins RM, Potter PM (2009) Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11). J Med Chem 52:3742–3752CrossRefGoogle Scholar
- Holmes RS, Wright MW, Laulederkind SJ, Cox LA, Hosokawa M, Imai T, Ishibashi S, Lehner R, Miyazaki M, Perkins EJ, Potter PM, Redinbo MR, Robert J, Satoh T, Yamashita T, Yan B, Yokoi T, Zechner R, Maltais LJ (2010) Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse and rate genes and proteins. Mamm Genome 21:427–441CrossRefGoogle Scholar
- Humerickhouse R, Lohrbach K, Li L, Bosron WF, Dolan ME (2000) Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer Res 60:1189–1192Google Scholar
- Potter PM, Wolverton JS, Morton CL, Wierdl M, Danks MK (1998) Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme. Cancer Res 58:3627–3632Google Scholar
- Robbi M, Beaufay H (1991) The COOH terminus of several liver carboxylesterases targets these enzymes in the lumen of the endoplasmic reticulum. Biochem Pharmacol 71:657–669Google Scholar
- Ross MK, Borazjani A (2007) Enzymatic activity of human carboxylesterases. Curr Protoc Toxicol 33:4.24.1–4.24.14Google Scholar
- Tyminski E, Leroy S, Terada K, Finkelstein DM, Hyatt JL, Danks MK, Potter PM, Saeki Y, Chiocca EA (2005) Brain tumor oncolysis with replication-conditional herpes simplex virus type1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. Cancer Res 65:6850–6857CrossRefGoogle Scholar
- Wadkins RM, Hyatt JL, Wei X, Yoon KJ, Wierdl M, Edwards CC, Morton CL, Obenauer JC, Damodaran K, Beroza P, Danks MK, Potter PM (2005) Identification and characterization of novel benzyl (diphenylethane-1,2-dione) analogue as inhibitors of mammalian carboxylesterases. J Med Chem 48:2906–2915CrossRefGoogle Scholar
- Williams ET, Bacon JA, Bender DM, Lowinger JJ, Guo WK, Eshani ME, Wang X, Wang H, Qian YW, Ruterbories KJ, Wrighton SA, Perkins EJ (2011) Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human. Drug Metab Dispos 39:2305–2313CrossRefGoogle Scholar